Can a Vaccine Built for One Ebola Virus Stop Another? The World Health Organization Is About to Find Out
WHO says the study could add Bundibugyo-specific vaccines later as more than 4,500 cases and 2,060 deaths are confirmed.
4 Articles
4 Articles
The Conversation
Medical XpressCan a vaccine built for one Ebola virus stop another? The World Health Organization is about to find out
The World Health Organization (WHO) has recommended prioritising the Ervebo vaccine for testing in a clinical trial in the Democratic Republic of the Congo. The vaccine was originally developed to protect against Zaire ebolavirus, the species responsible for the devastating west African epidemic just over a decade ago. It was not designed for the Bundibugyo species responsible for the current outbreak – which raises the question of why scientist…
WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus
The recommendation comes as researchers develop vaccines and treatments for the ongoing outbreak in the Democratic Republic of the Congo (DRC). The post WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus appeared first on Premium Times Nigeria.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
